logo-loader
viewKromek Group PLC

Kromek swells ranks of tech sector with £55mln AIM float

The tech sector has a new addition with Kromek Group making its debut on the junior market having raised £15mln in new investment that will fund its continued development. The new issue, at 51p a share, which values the group at £55mln, was oversubscribed.


london_350_525e34928fe19.jpg

The tech sector has a new addition with Kromek Group (LON: KMK) making its debut on the junior market having raised £15mln in new investment that will fund its continued development.

The new shares were issued at 51p a share, which values the group at £55mln, and the issue was oversubscribed.

The business is at the cutting-edge of x-ray technology and has developed products with cadmium zinc telluride (CZT) family of materials at their core.

Recognised as the premier components for digital and spectral radiation detectors, CZT compounds proved very difficult to produce in a commercially viable way.

Kromek’s technique has overcome these limitations based on research by Durham’s physics department.

Its CZT-based products provide high resolution information on material composition and structure, and they are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

Kromek chief executive Arnab Basu said: "We are delighted with our oversubscribed fundraising.

“After many years developing the business and our technology, Kromek is ready to begin harvesting value by seizing the opportunities to sell our technology and products into the medical imaging, security screening and nuclear detection markets.”

The proceeds from the initial public offering (IPO) will be used for product development, expansion of the sales and marketing team and investment into the company's intellectual property portfolio as well as paying down certain loans, the firm said.

The Kromek IPO is also a boon for Amphion Innovations (LON:AMP), the intellectual property group that has partnered the County Durham-based tech success story through its formative years.

Ampion has an 11.6% stake, which at the listing price, is worth £6.4mln. This is more than its current market capitalisation.

Amphion chief executive Richard Morgan said: "We are pleased Kromek has completed a successful listing on AIM and has raised the capital required to support its commercial targets.

“This is an exciting point in Kromek's development as it has substantial opportunities for growth.

“The listing and new capital will be important in securing further contracts for its leading technology in the medical imaging, security screening, and nuclear detection markets."


Quick facts: Kromek Group PLC

Price: 20.015 GBX

AIM:KMK
Market: AIM
Market Cap: £68.98 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Kromek Group PLC named herein, including the promotion by the Company of Kromek Group PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

New Kromek chairman Sir Peter Williams excited by opportunity

Proactive Investors speaks to Sir Peter Williams, science and engineering veteran and newly appointed chairman of Kromek (LON:KMK). Williams, who has also been chairman and chief executive of Oxford Instruments (LON:OXIG), says he hopes to sharpen the commercial and strategic focus of the...

on 09/28/2015

2 min read